Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPD1 | P10809 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | CPT2 | P23786 | 1/20 | 0.39 |
| ▸ | ACLY | P53396 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL891403 | 1.00 | HSPD1 (0.44) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL21055890 | 0.90 | HSPD1 (0.39) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL10439610 | 0.86 | HSPD1 (0.46) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL2557188 | 0.83 | HSPD1 (0.64) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL5926319 | 0.76 | HSPD1 (0.35) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL739847 | 0.75 | HSPD1 (0.37) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL16467958 | 0.74 | TSHR (0.40) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL20702119 | 0.74 | CPT2 (0.35) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL31390775 | 0.74 | ACLY (0.61) | HSPD1BLMHSPE1MEN1HPGD | |
| SCHEMBL9148021 | 0.74 | CPT2 (0.40) | HSPD1BLMHSPE1MEN1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3724307-B1 | LAUNDRY SURFACTANTS HAVING INHERENT BUILDING CAPACITY DERIVED FROM BIO-BASED HYDROYACIDS AND EPOXIDES; AND PROCESS THEREFORE | BATTELLE MEMORIAL INSTITUTE (US) | 2025-07-16 | — | — | EP | claimed |
| EP-2766050-B1 | PROCESS FOR THE PREPARATION OF HYPERPOLARIZED DERIVATIVES FOR USE IN MRI ANALYSIS | BRACCO IMAGING SPA (IT) | 2018-09-05 | — | — | EP | claimed |
| EP-3350306-A1 | RELEASE OF ODORIFEROUS SUBSTANCES FROM MICROCAPSULES | Henkel AG & Co. KGaA (DE) | 2018-07-25 | — | — | EP | claimed |
| EP-2203181-B1 | AN ORALLY ADMINISTERABLE SOLID PHARMACEUTICAL COMPOSITION AND A PROCESS THEREOF | BIOCON LTD (IN) | 2018-02-14 | — | — | EP | claimed |
| EP-3233821-A1 | ORTHOFORMIC ACID ESTERS AS PRO-FRAGRANCES | Henkel AG & Co. KGaA (DE) | 2017-10-25 | — | — | EP | claimed |
| WO-2017045893-A1 | RELEASE OF ODORIFEROUS SUBSTANCES FROM MICROCAPSULES | HENKEL AG & CO. KGAA (DE) | 2017-03-23 | — | — | WO | claimed |
| EP-2568974-B1 | ALCOHOL-RESISTANT ORAL PHARMACEUTICAL FORM | ETHYPHARM SA (FR) | 2017-01-04 | — | — | EP | claimed |
| US-9511154-B2 | Process for the preparation of hyperpolarized derivatives for use in MRI analysis | BRACCO IMAGING S.P.A. (IT) | 2016-12-06 | — | — | US | claimed |
| US-9468633-B2 | Oral controlled release dosage form | ANDRX PHARMACEUTICALS, INC. (US) | 2016-10-18 | — | — | US | claimed |
| US-9387178-B2 | Modified release tranexamic acid formulation | ACTAVIS, INC. (US) | 2016-07-12 | — | — | US | claimed |
| EP-1333816-A2 | MEDICINE BASED ON ANTI-HYPERGLYCAEMIC MICROCAPSULES WITH PROLONGED RELEASE AND METHOD FOR PREPARING SAME | FLAMEL TECHNOLOGIES (FR) | 2003-08-13 | — | — | EP | claimed |
| EP-1283701-A1 | A COATING COMPOSITION FOR FACILITATING CONTROLLED RELEASE | Ranbaxy Laboratories Limited (IN) | 2003-02-19 | — | — | EP | claimed |
| WO-2002094285-A1 | SINGLE-DAILY-DOSE ANTIDIABETIC ORAL PHARMACEUTICAL FORM COMPRISING A BIGUANIDE AND AT LEAST ANOTHER ACTIVE PRINCIPLE | FLAMEL TECHNOLOGIES (FR) | 2002-11-28 | — | — | WO | claimed |
| WO-2002039984-A2 | MEDICINE BASED ON ANTI-HYPERGLYCAEMIC MICROCAPSULES WITH PROLONGED RELEASE | FLAMEL TECHNOLOGIES (FR) | 2002-05-23 | — | — | WO | claimed |
| WO-2001087269-A1 | A COATING COMPOSITION FOR FACILITATING CONTROLLED RELEASE | RANBAXY LABORATORIES LIMITED (IN) | 2001-11-22 | — | — | WO | claimed |
| EP-0106443-B1 | PHARMACEUTICAL ORAL-CONTROLLED RELEASE MULTIPLE-UNITS FORMULATION | BENZON PHARMA A/S (DK) | 1991-07-17 | — | — | EP | claimed |
| EP-0066864-B1 | NEW CHEWING GUM BASE AND THEIR USE IN A CHEWING GUM | NABISCO BRANDS, Inc. (US) | 1986-03-05 | — | — | EP | claimed |
| US-4574080-A | TIME RELEASE DRUGS | A/S ALFRED BENZON (DK) | 1986-03-04 | — | — | US | claimed |
| US-4572833-A | COATING WITH MIXTURE OF SOLVENT, FILM-FORMING SUBSTANCE AND HYDROPHOBIC SUBSTANCE | A/S ALFRED BENZON (DK) | 1986-02-25 | — | — | US | claimed |
| EP-0106443-A2 | Pharmaceutical oral-controlled release multiple-units formulation | BENZON PHARMA A/S (DK) | 1984-04-25 | — | — | EP | claimed |